Relapse prevention by means of paroxetine in ECT‐treated patients with major depression: a comparison with imipramine and placebo in medium‐term continuation therapy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
In‐patients with severe major depression were treated in the acute phase with electroconvulsive therapy (ECT) in combination with antidepressants. The drug treatment consisted of two randomized trials which were both extended into the post‐ECT continuation phase. Patients with electrocardiological impairment were randomized to either 30 mg paroxetine daily or placebo under blind conditions. Patients without electrocardiological impairment were randomized to either 30 mg paroxetine daily or 150 mg imipramine daily. There was a high level of agreement between the Hamilton Depression Scale and the Melancholia Scale, demonstrating that the patients treated with ECT plus imipramine in the acute phase showed greater symptom reduction than those treated with ECT plus paroxetine. However, in the post‐ECT phase paroxetine was superior to both imipramine and placebo in preventing relapse. Thus in the post‐ECT phase 65% of the placebo‐treated patients relapsed, compared to 30% of the imipramine‐treated patients and 10% of the paroxetine‐treated patients. The psychometric analysis of the Melancholia Scale in the continuation or post‐ECT phase showed that relapsing patients displayed a pattern with lack of interests, impaired concentration, depressed mood and anxiety among the less severe symptoms (first‐compartment symptoms). In other words, these symptoms represent the gate to full‐blown depression (second‐compartment symptoms). Serotonin‐selective antidepressants such as paroxetine appear I to be more effective in controlling the first‐compartment symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Prien, R. F. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790220086014 · Cited by 565
Five-Year Outcome for Maintenance Therapies in Recurrent Depression
Kupfer, D. J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100013002 · Cited by 370
Relapse after recovery from unipolar depression: a critical review
Belsher, G., & Costello, C. G. (1988) · Psychological Bulletin · doi:10.1037/0033-2909.104.1.84 · Cited by 321
Continuation and maintenance therapy with antidepressive agents: Meta-analysis of research
Loonen, A. J. M., Peer, P. G. M., & Zwanikken, G. J. (1991) · Pharmaceutisch Weekblad Scientific Edition · doi:10.1007/bf01957741 · Cited by 79
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Sackeim, H. A., Haskett, R. F., Mulsant, B. H., Thase, M. E., Mann, J. J., Pettinati, H. M., Greenberg, R. M., Crowe, R. R., Cooper, T. B., & Prudic, J. (2001) · JAMA · doi:10.1001/jama.285.10.1299 · Cited by 686
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“In a controlled study of the post-ECT phase, paroxetine was shown to be superior to both imipramine and placebo in preventing relapse (Lauritzen et al. 1996).”
BackgroundFava, M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 603
Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Metadata
- Authors
- Lauritzen, L., Odgaard, K., Clemmesen, L., Lunde, M., Öhrström, J., Black, C., & Bech, P.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 1996-10
- Volume
- 94
- Issue
- 4
- Pages
- 241-251
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W2150208128
- Cited by
- 124
- References
- 5
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relapse prevention by means of paroxetine in ECT‐treated patients with major depression: a comparison with imipramine and placebo in medium‐term continuation therapy. https://app.cochat.ai/papers/10.1111/j.1600-0447.1996.tb09856.x
- The paper
- Lauritzen, L., Odgaard, K., Clemmesen, L., Lunde, M., Öhrström, J., Black, C., & Bech, P. (1996). Relapse prevention by means of paroxetine in ECT‐treated patients with major depression: a comparison with imipramine and placebo in medium‐term continuation therapy. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1996.tb09856.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.